Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab and ALT-803 in Advanced Non-Small Cell Lung Cancer
NCT02523469Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2016
- Primary completion
- Feb 2023
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of nogapendekin alfa inbakicept in non-small cell lung cancer (NSCLC), sponsored by Medical University of South Carolina. Started Jan 2016; status: completed.
02
Drugs
nogapendekin alfa inbakicept
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02523469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02523469.